TECHNICAL SPECIFICATIONS
| Item | Specification |
|---|---|
| Product Name | Eptifibatide Acetate |
| CAS NO. | 148031-34-9/188627-80-7 |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | C35H49N11O9S2 |
| Molecular Weight | 831.96 g/mol |
| Purity (RP-HPLC) | ≥98.0% |
| Solubility | Soluble in water; sparingly soluble in ethanol |
| Endotoxin | ≤5 EU/mg |
| Biological Activity | Potent inhibitor of platelet GP IIb/IIIa receptor; prevents platelet aggregation in vitro |
| Storage Conditions | Store at 2–8°C, protected from light and moisture |
| Stock Location | Stock in USA |
| MOQ | 1g |
Eptifibatide Acetate functions as a potent and selective antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor. It competitively inhibits the binding of fibrinogen and von Willebrand factor to this receptor, thereby blocking the final common pathway of platelet aggregation. Unlike monoclonal antibodies, it is a small molecule peptide that binds reversibly, allowing for rapid onset of action and a short plasma half-life of approximately 2.5 hours, which provides clinicians with greater control over the antiplatelet effect and facilitates quick reversal if bleeding complications arise.

This product is indicated for use in the treatment of patients with Acute Coronary Syndrome (ACS), including unstable angina and non-ST-elevation myocardial infarction (NSTEMI), as well as for patients undergoing Percutaneous Coronary Intervention (PCI). It is specifically designed for high-risk patients who require aggressive antiplatelet therapy to prevent ischemic cardiac events, and it is typically administered in conjunction with aspirin and heparin to reduce the incidence of thrombotic complications during and after coronary procedures.

Clinical trials, such as the PURSUIT and ESPRIT studies, have demonstrated that Eptifibatide Acetate significantly reduces the combined endpoint of death or new myocardial infarction in ACS patients. In the PCI setting, it has been shown to lower the risk of periprocedural complications and the need for urgent repeat revascularization. Its efficacy profile is marked by a substantial reduction in ischemic events while maintaining a manageable safety window due to its reversible binding, making it a cornerstone therapy for preventing platelet-mediated thrombosis in interventional cardiology.
4.Certificate
GlobalTech Co., Ltd. is committed to providing high-purity biotechnological peptide products, adhering strictly to quality standards and obtaining internationally recognized certifications.
Our production partners all employ GMP-compliant production systems and possess standardized quality control processes covering raw material procurement, synthesis, purification, testing, packaging, and storage. Each batch of product comes with complete documentation, including a Certificate of Analysis (COA), HPLC purity report, mass spectrometry (MS) chromatograms, and third-party testing reports available upon request.
We prioritize:
1.A rigorous quality management system
2.Batch traceability and stability data
3.Professional laboratory testing and validation
4.Compliance with international trade standards
Our commitment to quality, transparency, and regulatory compliance ensures the provision of reliable, stable, and research-grade peptide products to our global partners.

5.DELIVERY & SHIPPING
We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight
We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Global Technology Co., Ltd. is a modern and advanced enterprise specializing in the production and export of active pharmaceutical ingredients (APIs), peptides, and plant extracts. The company invests in and collaborates closely with domestic manufacturers holding GMP, DMF, and FDA certifications, as well as laboratories at renowned universities, to meet diverse customer needs ranging from gram-level to ton-level. This enables Dejurui Pharmaceutical to provide customers with more flexible and convenient access to cost-effective, high-quality products and superior services.
We focus on the research and development and supply of high-quality chemical products, strictly adhering to international standards and quality systems. Our products are stable in performance and reliable in purity, widely used in industrial manufacturing, scientific research, and the fine chemical industry. We provide solid support at every stage with a professional and responsible attitude.
Hot Tags:Eptifibatide, Integrilin, GPIIb/IIIa inhibitor, Antiplatelet agent, Cyclic heptapeptide, ACS treatment, PCI medication, Cardiovascular drug, Peptide API, Thrombosis prevention, Supplier, Manufacturer, Bulk order, Pharmaceutical.
If you have any product requirements, please send an email to:info@huanqiukeji9.com;whatsapp:85246842553